Status:
ACTIVE_NOT_RECRUITING
Role of Intestinal Ultrasound in Treat to Target Strategy in the Management of Inflammatory Bowel Disease : the IUS-TTT Study
Lead Sponsor:
Asian Institute of Gastroenterology, India
Conditions:
Crohn Disease
Ulcerative Colitis
Eligibility:
All Genders
18-70 years
Brief Summary
This study aims to evaluate the role of bedside Intestinal Ultrasound (IUS) as a cost-effective, non-invasive, and well-tolerated procedure within the Treat-to-Target strategy for managing Inflammator...
Detailed Description
This prospective observational pilot study aims to assess the role of Intestinal Ultrasound (IUS) in the management of active Inflammatory Bowel Disease (IBD) over a 6-12 month period at a single tert...
Eligibility Criteria
Inclusion
- Adults over the age of 18 years.
- Active Crohn's disease, defined as a Simple Endoscopic Score for Crohn's Disease of 3 or higher.
- Active ulcerative colitis, defined as an Ulcerative Colitis Endoscopic Index of Severity of 2 or higher.
Exclusion
- Age \< 18 years
- Intestinal ultrasound for assessment of response to therapy
- Intestinal ultrasound for clinically asymptomatic disease
- Pregnancy and lactating mothers
Key Trial Info
Start Date :
April 5 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 4 2026
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT06534216
Start Date
April 5 2024
End Date
March 4 2026
Last Update
July 17 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Asian Institute of Gastroenterology
Hyderabad, Telangana, India, 500082